[go: up one dir, main page]

WO2001095723A1 - Composition parasiticide - Google Patents

Composition parasiticide Download PDF

Info

Publication number
WO2001095723A1
WO2001095723A1 PCT/GB2001/002610 GB0102610W WO0195723A1 WO 2001095723 A1 WO2001095723 A1 WO 2001095723A1 GB 0102610 W GB0102610 W GB 0102610W WO 0195723 A1 WO0195723 A1 WO 0195723A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition according
composition
imidazole
triazole
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/002610
Other languages
English (en)
Inventor
Ian Whelan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSL International PLC
Original Assignee
SSL International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0014667A external-priority patent/GB0014667D0/en
Priority claimed from GB0019255A external-priority patent/GB0019255D0/en
Priority claimed from GB0027435A external-priority patent/GB0027435D0/en
Application filed by SSL International PLC filed Critical SSL International PLC
Priority to AU2001264110A priority Critical patent/AU2001264110A1/en
Publication of WO2001095723A1 publication Critical patent/WO2001095723A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Definitions

  • the invention relates to a parasiticidal composition and in particular to a composition for controlling headlice infestation in humans.
  • Lice infestation in man is generally caused by insects from the families Pediculidae and Pthiridae, in particular Pedicuhis humanus species and Pthirus pubis.
  • the azole antifungal agents have five-membered organic rings that contain either two or three nitrogen molecules (the imidazoles and the triazoles respectively). Two types of antifungal affect the cell membrane-polyenes and imidazoles.
  • the clinically useful imidazoles are clotrimazole, miconazole, and ketoconazole, two important triazoles are itraconazole and fluconazole.
  • the azole antifungal agents are thought to inhibit cytochrome P 50 - dependent enzymes involved in the biosynthesis of cell membranes
  • kitoconazole was the original model for the orally administered antifungal azoles. It can be administered both orally and topically and has a range of activity including infections. It is also active against mucosal candidiasis and a variety of cutaneous mycoses, including dermatophyte infections, pityriasis versicolor, and cutaneous candidiasis.
  • the triazoles (fluconazole, itraconazole) have become the standard for the azoles, and have replaced amphotericin B for managing certain forms of the systemic mycoses.
  • the compounds work by binding to sterols in the cell membrane.
  • the principal sterol in fungal cell membranes is ergosterol, while the principal sterol in mammalian cell membranes is cholesterol.
  • Polyenes have a stronger affinity for ergosterol than cholesterol, so they show greater activity against fungal cells than mammalian cells.
  • the binding forms channels of about 0.8nm in diameter, which in turn allows leakage of up to 90% of cellular potassium ions (K+). This is followed by a loss of magnesium ions (Mg++). The loss of K+ ions inhibits a variety of metabolic processes, including glycolysis and respiration.
  • Imidazoles bind to the fungal cytochrome P- 45 o. This inhibits production of ergosterol synthesis or its incorporation into the cell membrane. This interferes with the membrane function and permeability. This means many components, including K+, leak out of the cell. Examples include ketoconazole, miconazole, econazole, fluconazole, clotrimazole, and intraconazole. According to the present invention there is provided a parasiticidal composition comprising an imidazole and/or a triazole and a physiologically acceptable carrier.
  • the imidazole is selected from one or more of the group consisting of clotrimazole, ketoconazole, and miconazole and that the triazole is selected from fluconazole and itraconazole.
  • composition is adapted for topical application to a subject. It is particularly preferred that the composition is adapted for application as a lotion or mousse for the hair.
  • composition may further comprise alcohol, such as isopropanol and/or ethanol, and the physiologically acceptable carrier may comprise the alcohol.
  • alcohol such as isopropanol and/or ethanol
  • physiologically acceptable carrier may comprise the alcohol.
  • composition may comprise at least about 0.2% v/v imidazole and/or triazole.
  • the composition may further comprise a constituent having ovicidal activity.
  • the ovicidal agent may comprise a terpene, preferably one or both of d- limonene and geranyl acetate.
  • composition is for use in the treatment and/or prevention of human infestation by parasites from the families Pediculidae and Pthiridae.
  • a process for preparing a parasiticidal composition which comprises bringing an imidazole and/or a triazole into association with at least one carrier therefor.
  • a process for preparing a parasiticidal composition which comprises bringing an imidazole and/or a triazole into association with at least one carrier therefor.
  • an imidazole and/or a triazole in the manufacture of a composition for use in controlling parasite infestations in humans, in particular infestation by parasites from the families Pediculidae and Pthiridae.
  • Human lice pediculus humanus, were obtained from the culture colony maintained by the Medical Entomology Centre. Adult female and male lice, in approximately equal numbers, were used for each test. The lice were fed on the morning of the test and allowed a minimum of 4 hours to recover, during which time they were able to excrete excess water imbibed with their blood meal. Lice were counted into batches that were provided with squares of an open meshed nylon gauze (tulle), as a substrate upon which to stand, and each batch allocated to a marked 30 millimetre plastic Petri dish.
  • tulle open meshed nylon gauze
  • the gauze bearing lice was immersed in the fluid for 10 seconds, during which time the gauze was turned at least twice to ensure removal of air bubbles. After removal from the fluid the gauze and insects were lightly blotted to remove excess fluid and returned to their marked Petri dish. The same procedure was repeated for the other replicate gauze squares in that batch.
  • Gauze squares bearing lice were incubated under normal maintenance conditions (30° ⁇ 2° Celsius and 50% ⁇ 15% relative humidity) for the remainder of the test period.
  • the insects and gauze were washed using a bland toiletry shampoo (Boots frequent wash shampoo) diluted one part shampoo with fourteen parts water (FWS 1:15) after which they were rinsed three times using 250 millilitres of warm (34° Celsius) tap water poured through and over the gauze squares. They were then blotted dry using medical wipe tissue and incubated under normal maintenance conditions in clean plastic Petri dishes of the appropriate size until the results were recorded.
  • Mortality percentages were corrected by Abbott's formula. The percent of mortality in a control was subtracted from the percent mortality in the test and then divided by the percent mortality in the test.
  • An insect's exoskeleton serves not only as a protective covering over the body, but also as a surface for muscle attachment, a water-tight barrier against desiccation, and a sensory interface with the environment.
  • the typical insect exoskeleton is a multi-layered structure with four functional regions, epicuticle, procuticle, epidermis, and basement membrane.
  • the epidermis is a single layer of epithelial cells. It is responsible for producing at least part of the basement membrane as well as all of the overlying layers of cuticle.
  • the procuticle lies immediately above the epidermis. It contains microfibers of chitin surrounded by a matrix of protein that varies in composition from insect to insect and even from place to place within the body of a single insect.
  • procuticle stratifies into a hard, outer exocuticle and a soft, inner endocuticle.
  • exocuticle Differentiation of exocuticle involves a chemical process (called sclerotization) that occurs shortly after each molt.
  • sclerotization individual protein molecules are linked together by quinone compounds. These reactions "solidify” the protein matrix, creating rigid "plates” of exoskeleton known as sclerites.
  • Quinone cross-linkages do not form in parts of the exoskeleton where resilin (an elastic protein) is present in high concentrations. These areas are membranes and they remain soft and flexible because they never develop a well-differentiated exocuticle.
  • the epicuticle is the outermost part of the cuticle. Its function is to reduce water loss and block the invasion of foreign matter.
  • the innermost layer of epicuticle is often called the cuticulin layer, a stratum composed of lipoproteins and chains of fatty acids.
  • a layer of wax molecules lies just above the cuticulin layer, it serves as a barrier to movement of water into or out of the insect's body. In many insects a cement layer covers the wax and protects it from abrasion.
  • imidazoles act as either sclerotisizers or they simply cause a diffusion gradient across the louse resulting in death.
  • the results tend to indicate also that this effect may be enhanced by the use of an alcoholic vehicle.
  • formulations having parasiticidal activity were prepared as follows:
  • formulations which can be prepared in accordance with this invention include lotions and mousses as well as, potentially, other hair treatments.
  • additional constituents which are required will vary according to the desired properties of the final product.
  • the skilled worker will be familiar with such constituents and their usage, which can include, for example, surfactants, silicone compounds, suspending agents colourings and perfumes.
  • compositions according to the invention To enhance the activity of the compositions according to the invention it has been found that further constituents having ovicidal activity can be added without adversely affecting their efficacy.
  • further constituents are terpenes and in particular, the te ⁇ enes d-limonene and geranyl acetate can be used, each at a concentration of from 0.2% v/v to 1.0% v/v.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un imidazole sélectionné dans un ou plusieurs groupes comprenant clotrimazole, kétoconazole et miconazole, le triazole étant sélectionné parmi fluconazole et itraconazole.
PCT/GB2001/002610 2000-06-15 2001-06-15 Composition parasiticide Ceased WO2001095723A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264110A AU2001264110A1 (en) 2000-06-15 2001-06-15 Parasiticidal composition

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0014667A GB0014667D0 (en) 2000-06-15 2000-06-15 Parasiticidal composition
GB0014667.0 2000-06-15
GB0019255.9 2000-08-04
GB0019255A GB0019255D0 (en) 2000-08-04 2000-08-04 Parasiticidal composition
GB0027435A GB0027435D0 (en) 2000-11-09 2000-11-09 Parasiticidal composition
GB0027435.7 2000-11-09

Publications (1)

Publication Number Publication Date
WO2001095723A1 true WO2001095723A1 (fr) 2001-12-20

Family

ID=27255766

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/002610 Ceased WO2001095723A1 (fr) 2000-06-15 2001-06-15 Composition parasiticide

Country Status (2)

Country Link
AU (1) AU2001264110A1 (fr)
WO (1) WO2001095723A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070421A1 (fr) * 2004-01-22 2005-08-04 Alparis S.A. De C.V. Association de fluconazole-tinidazole pour le traitement d'infections vaginales, sa composition, son procede de preparation et son utilisation

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565992A (en) * 1968-03-08 1971-02-23 Dow Chemical Co Halogenated imidazole and imidazole salts used for controlling insect and helminth parasites
GB2092582A (en) * 1981-02-09 1982-08-18 Ciba Geigy Ag Substituted 2-(anilinomethyl)- 2-imidazoline derivatives and pesticidal compositions containing them
EP0113945A1 (fr) * 1983-01-19 1984-07-25 Eli Lilly And Company Sels d'amines
EP0496316A1 (fr) * 1991-01-19 1992-07-29 Hoechst Aktiengesellschaft Formulation de pour-on pour application d'agents anthelmintiques
US5174475A (en) * 1991-03-26 1992-12-29 Glaxo Inc. Sequential dosing of antifungal and antiinflammatory compositions
WO1993018010A1 (fr) * 1992-03-12 1993-09-16 Pfizer Limited Agents anthelminthiques a base de benzimidazole
EP0712847A1 (fr) * 1993-08-11 1996-05-22 Nippon Soda Co., Ltd. Derive d'imidazole et son procede de production, et substance anti-nuisibles
WO1997036486A1 (fr) * 1996-03-29 1997-10-09 Merial Solution cutanee pour depot direct a usage anti-parasitaire chez les bovins et ovins
EP0957094A1 (fr) * 1998-05-14 1999-11-17 Pfizer Inc. 1-(2-Halogénaryl)azoles comme agents antiparasitaires

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565992A (en) * 1968-03-08 1971-02-23 Dow Chemical Co Halogenated imidazole and imidazole salts used for controlling insect and helminth parasites
GB2092582A (en) * 1981-02-09 1982-08-18 Ciba Geigy Ag Substituted 2-(anilinomethyl)- 2-imidazoline derivatives and pesticidal compositions containing them
EP0113945A1 (fr) * 1983-01-19 1984-07-25 Eli Lilly And Company Sels d'amines
EP0496316A1 (fr) * 1991-01-19 1992-07-29 Hoechst Aktiengesellschaft Formulation de pour-on pour application d'agents anthelmintiques
US5174475A (en) * 1991-03-26 1992-12-29 Glaxo Inc. Sequential dosing of antifungal and antiinflammatory compositions
WO1993018010A1 (fr) * 1992-03-12 1993-09-16 Pfizer Limited Agents anthelminthiques a base de benzimidazole
EP0712847A1 (fr) * 1993-08-11 1996-05-22 Nippon Soda Co., Ltd. Derive d'imidazole et son procede de production, et substance anti-nuisibles
WO1997036486A1 (fr) * 1996-03-29 1997-10-09 Merial Solution cutanee pour depot direct a usage anti-parasitaire chez les bovins et ovins
EP0957094A1 (fr) * 1998-05-14 1999-11-17 Pfizer Inc. 1-(2-Halogénaryl)azoles comme agents antiparasitaires

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070421A1 (fr) * 2004-01-22 2005-08-04 Alparis S.A. De C.V. Association de fluconazole-tinidazole pour le traitement d'infections vaginales, sa composition, son procede de preparation et son utilisation

Also Published As

Publication number Publication date
AU2001264110A1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
AU2009317951B2 (en) Antimicrobial foamable soaps
US20080039351A1 (en) Antimicrobial and sporicidal composition
FR2483177A1 (fr) Nouvelle composition desinfectante comprenant un ammonium quaternaire et un oligomere de chlorhydrate d'hexamethylene biguanide
JP5179879B2 (ja) 組成物
EP3174391B1 (fr) Composition d'étalement liquide sans siloxane comprenant de l'isopropylmyristate et de l'isohexadécane pour la lutte contre les ectoparasites
US20120115812A1 (en) Surface coatings for skin
CA2636712C (fr) Formule pediculicide/ovicide
WO2001095726A1 (fr) Composition antiparasitaire
JP5535209B2 (ja) 抗菌組成物
WO2001095723A1 (fr) Composition parasiticide
ITMI20061825A1 (it) Composizione antipediculosi provvista di attivita' di soffocamento dei pidocchi
KR102018128B1 (ko) 여드름 개선을 위한 pH 감응성 화장료 조성물 및 이의 제조방법
KR20050059141A (ko) 항진균제 및 항세균제 배합 세정용 조성물
CN111479551B (zh) 包含抗菌脂质的局部用组合物
JP2007501208A (ja) 殺寄生生物組成物
EP1512409B1 (fr) Agent pour le traitement des poux de la tête
KR102235754B1 (ko) 구충제를 이용한 피부 염증의 예방 및 개선용 화장품
CN114096229B (zh) 双脱水己糖醇用于消除痤疮、头皮屑和异味对仪容仪表的影响的用途
EP3785540A1 (fr) Polyisobutène à utiliser dans le traitement ou la prévention d'une infection par les arthropodes
KR102150494B1 (ko) 모낭충 여드름, 지루성 피부염 및 일과성 가시세포 염증의 예방, 개선 및 치료를 목적으로 하는 화장료 조성물
EP3946237B1 (fr) Utilisation de dianhydrohexitol pour la conservation des préparations cosmétiques
EP3280394B1 (fr) Gel a base de sel et son utilisation dans la prévention et le traitement des parasitoses et des affections dermatologiques
KR100768401B1 (ko) 무좀방지용 화장료 조성물
KR20110058260A (ko) 화장료 조성물
FR3094216A1 (fr) Utilisation de dianhydrohexitol pour éliminer les effets cosmétique des mauvaises odeurs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP